<?xml version="1.0" encoding="UTF-8"?>
<records xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://www.doaj.org/schemas/doajArticles.xsd">


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2019-01-04</publicationDate>
              <volume>3</volume>
              <issue>3</issue>
              <startPage>102</startPage>
              <endPage>109</endPage>
              <doi>10.26663/cts.2019.00020</doi>
              <publisherRecordId>55</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Pneumonectomy; a risky type of resection in non-small cell lung cancer: survival and mortality analysis</title>
                <authors>
                              <author>
                                <name>Serkan  Yazgan</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Soner  Gursoy</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ahmet  Ucvet</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ozgur  Samancilar</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ahmet Emin Erbaycu</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Mehmet  Unal</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Tarik  Yagci</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, University of Health Sciences, Dr. Suat Seren Chest Diseases and Surgery Medical Practice and Research Center, İzmir, Turkey</affiliationName><affiliationName affiliationId="2">Department of Chest Diseases, University of Health Sciences, Dr. Suat Seren Chest Diseases and Surgery Medical Practice and Research Center, İzmir, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background:&lt;/b&gt; This study aims to evaluate the mortality and survival rates of patients undergoing
pneumonectomy due to primary non-small cell lung cancer (NSCLC) and to identify the factors which
affect these variables.&lt;p&gt;
&lt;b&gt;Materials and Methods: &lt;/b&gt;This retrospective single center cohort study included a total of 250 patients
who underwent pneumonectomy due to NSCLC between January 2007 and July 2015. 30- and 90-day
mortality rates and survival rates of the patients were analyzed. The factors which affected survival and
mortality were evaluated.&lt;p&gt;
&lt;b&gt;Results: &lt;/b&gt;The mean age was 59 (range: 35 to 77) years. The median survival was 48.1 months (95%
C. I. 30.6 – 65.6 months) and five-year survival rate was 45.6%. The 30- and 90-day mortality rates
were 6.4% and 7.6%, respectively. Age, nodal disease, and complete resection were factors to affect the
survival (p = 0.002, p = 0.0001 and p = 0.017, respectively). Age was also effective on 30- and 90-day
mortality (p = 0.004, RR: 3.3 and p = 0.006, RR: 2.5, respectively). The early rethoracotomy rate was
5.6% (n = 14) and the postoperative mortality rate in these patients was 28.6% (n = 4).&lt;p&gt;
&lt;b&gt;Conclusions: &lt;/b&gt;Although implementation of pneumonectomy due to lung cancer seems fearful, the
present study found lower survival rates only depending on advanced age and N2 disease. The high
levels of 30- and 90-day mortality and the increased mortality after early rethoracotomy was associated
with advanced age and comorbidity. In terms of postoperative mortality, the selection of eligible patients
is important in elderly patients who are candidates of pneumonectomy due to lung cancer.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=55</fullTextUrl>
              <keywords><keyword>non-small cell lung cancer</keyword><keyword>pneumonectomy</keyword><keyword>survival rate</keyword><keyword>early mortality</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2019-01-04</publicationDate>
              <volume>3</volume>
              <issue>3</issue>
              <startPage>110</startPage>
              <endPage>115</endPage>
              <doi>10.26663/cts.2019.00021</doi>
              <publisherRecordId>56</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Is surgical treatment effective option for survival of small cell lung cancer?</title>
                <authors>
                              <author>
                                <name>Celal Buğra Sezen</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Umut  Kilimci</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Oğuz  Girgin</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Yunus  Aksoy</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ozkan  Saydam</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Seyyit İbrahim Dincer</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Muzaffer  Metin</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Health Sciences University, Chest Diseases and Thoracic Surgery Health Application and Research Center, Istanbul, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background: &lt;/b&gt;Small cell lung cancer (SCLC) accounts for 10% of all lung cancers. Due to the fact that
it is an aggressive tumor, there is still no consensus on treatment. Our aim in this study was to evaluate
prognostic factors affecting survival in early-stage small cell lung cancer.&lt;p&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt; Between 2008 and 2017, 21 patients who underwent resection due to earlystage
SCLC were evaluated retrospectively in the study. 16 (76.2%) stage I and 5 (23.8%) stage II
patients were included in the study. All patients received adjuvant therapy after surgery.&lt;p&gt;
&lt;b&gt;Results: &lt;/b&gt;Sixteen (76.2%) male and 5 (23.8) female patients were included in the study. The mean
age was 60.19 ± 7.13 years. Patients were followed for a mean of 33 months. There was 16 (76.2%)
small cell, and 5 (23.6%) combined small cell carcinoma. The 5-year survival rate was 48.6% (59.6 ±
10.6 months). In 7 patients (33.3%) postoperative morbidity was observed. No statistically significant
difference was found between N status and survival. Statistically significant differences were found
between tumors smaller than 1 cm and tumors greater than 1 cm in terms of T stage (p = 0.043).&lt;p&gt;
&lt;b&gt;Conclusions:&lt;/b&gt; In conclusion, multimodal treatment is very important for survival in early-stage small
cell lung cancer. Although our results in our study are aggressive tumors of the SCLC, survival outcomes
in the early stages are quite satisfactory. Early stage survival outcomes, especially after stage I tumors,
are as successful as non-small cell lung cancers.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=56</fullTextUrl>
              <keywords><keyword>small cell lung cancer</keyword><keyword>lobectomy</keyword><keyword>prognostic factors</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2019-01-04</publicationDate>
              <volume>3</volume>
              <issue>3</issue>
              <startPage>116</startPage>
              <endPage>122</endPage>
              <doi>10.26663/cts.2019.00022</doi>
              <publisherRecordId>57</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Can neutrophil to lymphocyte ratio and platelet to lymphocyte ratio predict the severity of sternum fractures?</title>
                <authors>
                              <author>
                                <name>Muharrem  Özkaya</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Cihan  Bedel</name>
                                <affiliationId>2</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Health Sciences University, Antalya Training and Research Hospital, Antalya, Turkey</affiliationName><affiliationName affiliationId="2">Department of Emergency Medicine, Health Sciences University, Antalya Training and Research Hospital, Antalya, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background:&lt;/b&gt; Although the NLR and PLR are cheap and widely available biomarkers, literature
regarding their usage in trauma patients is scarce. It seemed to us interesting to evaluate the prognostic
value of the NLR and PLR for trauma patients. In this manner, we selected a small group of trauma
patients with sternal fractures and aimed to investigate their correlation with the serum NLR and PLR.
To the best of our knowledge, this is the first study investigating the clinical value of these cheap and
widely available biomarkers in trauma patients.&lt;p&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt; We designed a retrospective study examining the utility of NLR and PLR in
estimating trauma severity in sternum fracture patients who admitted to our hospital between January
2013 and April 2018. Patients were divided into two groups: isolated sternum fracture group (36 patients
with sternal fracture and without any complications in thorax or other system and/or only 1 or 2 rib
fractures) and complicated sternum fracture group (19 patients with sternal fracture and with associated
complications in thorax or other systems). Injuries were not graded but referred as severe according to
the associated complications in thorax or other systems. The key clinical parameters, including NLR
and PLR were compared among the groups.&lt;p&gt;
&lt;b&gt;Results: &lt;/b&gt;Based on the ROC curve, the best NLR cut-off value to predict complicated sternum fracture
group patients was 2.1, with 88.9% sensitivity and 28% specificity, whereas the best PLR cut-off value
was 123.8, with 72% sensitivity and 68% specificity.&lt;p&gt;
&lt;b&gt;Conclusions:&lt;/b&gt; The results may indicate a clinically useful marker that can be easily and reliably measured
from a blood sample to predict outcome of trauma patients with sternal fractures.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=57</fullTextUrl>
              <keywords><keyword>sternum fracture</keyword><keyword>neutrophil</keyword><keyword>lymphocyte</keyword><keyword>platelet</keyword><keyword>ratio</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2019-01-04</publicationDate>
              <volume>3</volume>
              <issue>3</issue>
              <startPage>123</startPage>
              <endPage>127</endPage>
              <doi>10.26663/cts.2019.00023</doi>
              <publisherRecordId>58</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Comparison of the outcomes of the implanted subcutaneous ports in cancer patients: six-years single center experience</title>
                <authors>
                              <author>
                                <name>Ali Cevat Kutluk</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Hasan  Akın</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Yedikule Chest Disease and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background:&lt;/b&gt; The preferred site of venous access ranges from deep veins (internal jugular or subclavian
veins) to superficial veins (external jugular, anterior jugular, and upper limb veins). The aim of the
study is to evaluate experience of single surgeon and compare the outcomes of the subclavian (SCV),
internal jugular (IJV), and external jugular (EJV) veins in terms of procedure time and complications
retrospectively.&lt;p&gt;
&lt;b&gt;Materials and Methods: &lt;/b&gt;The study included 327 patients who had port placement between 2012 and
2018. The mean age of all cases was 55.67 years, and the patients were divided into 3 groups according
to venous sites; subclavian (SCV), internal jugular (IJV), and external jugular veins (EJV). Only local
anesthesia was given and no antibiotic prophylaxis was provided before the intervention. The 3 groups
were compared regarding age, sex, primary tumor site, procedure time, and complications.&lt;p&gt;
&lt;b&gt;Results:&lt;/b&gt; The procedure was significantly longer in the SCV group than the other 2 (43.35 min vs 34.58 and
33.71 min). Removal of the catheter was less common in the IJV group than the other 2 groups. Overall
complications in the IJV group were lower than the other 2 groups, especially catheter malposition and
pneumothorax rates were lower in the IJV group.&lt;p&gt;
&lt;b&gt;Conclusions: &lt;/b&gt;In light of the findings of the study implantable port placement via internal jugular vein is
safe and had lower complication rates than either the subclavian or external jugular veins.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=58</fullTextUrl>
              <keywords><keyword>cancer</keyword><keyword>chemotherapy</keyword><keyword>implantable venous port</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2019-01-04</publicationDate>
              <volume>3</volume>
              <issue>3</issue>
              <startPage>128</startPage>
              <endPage>132</endPage>
              <doi>10.26663/cts.2019.00024</doi>
              <publisherRecordId>59</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Pediatric foreign body aspirations: experience of 263 cases</title>
                <authors>
                              <author>
                                <name>Ozgur  Katrancioglu</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Sule  Karadayi</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Ekber  Sahin</name>
                                <affiliationId>2</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, School of Medicine, Omer Halisdemir University, Niğde, Turkey</affiliationName><affiliationName affiliationId="2">Department of Thoracic Surgery, School of Medicine, Cumhuriyet University, Sivas, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background:&lt;/b&gt; Foreign body (FB) aspiration is a serious clinical situation due to its life-threatening
status and especially common in the childhood period. We aimed to present the diagnosis and treatment
of foreign bodies in pediatric age group.&lt;p&gt;
&lt;b&gt;Material and Methods: &lt;/b&gt;Files of 510 patients aged 16 years and below that underwent rigid bronchoscopy
due to suspicion of FB aspiration between June 1994 and November 2017 were retrospectively reviewed.
263 cases were included to the study that underwent foreign body removal. The cases were assessed in
terms of gender, age, type and localization of the foreign body, clinical complaint, radiological findings,
treatment method, complication and mortality.&lt;p&gt;
&lt;b&gt;Results: &lt;/b&gt;Among the patients 45.6% were male and 54.4% were female. The aspirated foreign bodies
varied from dried nuts to plastic, from hijab needles to beads. The most aspirated foreign body were dried
nuts. 51% of them were removed from the right main bronchus, 31.9% from the left main bronchus, and
17.1% from the trachea. 97.8% of the foreign bodies were removed via bronchoscope. Thoracotomy
was performed in 6 cases since the foreign bodies were not extractable with a bronchoscope or due to
developing complications. No mortality occurred.&lt;p&gt;
&lt;b&gt;Conclusions: &lt;/b&gt;FB aspiration can lead to life-threatening complications in children aged 3 years or
below. Bronchoscopy should be performed in all cases of foreign body aspiration, including suspicious
cases. Notably, the bronchoscopy procedure should be carried out by a well-trained, experienced
anesthesiologist-endoscopy team and with appropriate tools.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=59</fullTextUrl>
              <keywords><keyword>childhood period foreign body aspirations</keyword><keyword>trachea</keyword><keyword>bronchus</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2019-01-04</publicationDate>
              <volume>3</volume>
              <issue>3</issue>
              <startPage>133</startPage>
              <endPage>137</endPage>
              <doi>10.26663/cts.2019.00025</doi>
              <publisherRecordId>60</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Evaluation of characteristics of the patients who undergo surgical treatment for lung hydatid cyst</title>
                <authors>
                              <author>
                                <name>Ersin  Sapmaz</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Kuthan  Kavaklı</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Merve Sengul Inan</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Hakan  Isık</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Okan  Karatas</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Deniz  Dogan</name>
                                <affiliationId>3</affiliationId>
                              </author>
                              <author>
                                <name>Hasan  Caylak</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Sedat  Gurkok</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, University of Health Sciences, Gülhane Training and Research Hospital, Ankara, Turkey</affiliationName><affiliationName affiliationId="2">Thoracic Surgery Clinic, Sinop Ataturk State Hospital, Sinop, Turkey</affiliationName><affiliationName affiliationId="3">Department of Pulmonology, University of Health Sciences, Gülhane Training and Research Hospital, Ankara, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background:&lt;/b&gt; Hydatid cyst is a public health problem, particularly where it is endemic. It is a benign
disease and usually asymptomatic unless the symptoms and complications develop. Effective treatment
is important because this benign disease can cause considerable mortality and morbidity. The aim of
this study was to describe the epidemiological and clinical characteristics of HC, localization (bilateral
lungs or multiple organ involvement) and perforation characteristics of HC.&lt;p&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt; 160 patients were operated on for pulmonary hydatid disease for about
approximately 12 years of time period. Patients were evaluated according to their age, gender, distribution
of cysts in the lung, extra-pulmonary organ involvements, presence or absence of perforations, and
animal contact stories.&lt;p&gt;
&lt;b&gt;Results: &lt;/b&gt;Number of the cysts, the cyst diameter, gender, location of the cysts and the liver involvement
were found unrelated with the perforation status of the cyst. But, there is a significant difference between
the localization of the cysts in the lung and the involvement of the liver. The rates of presence of liver
cysts in the case of unilateral right, unilateral left and bilateral cysts in the lung were found as 13%, 25%
and 50% respectively.&lt;p&gt;
&lt;b&gt;Conclusions: &lt;/b&gt;Hydatid cyst is a public health problem and elimination is possible with rigorous work.
In case of bilateral pulmonary cysts and the multiple number of cysts, the likelihood of a cyst in the
liver is increased. It was concluded that there was no relationship between the presence of cysts in the
liver and the absence of perforation in the lung cysts. However, it should be kept in mind in terms of
the possible complications that may occur at high perforations in patients who received preoperative
albendazole therapy.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=60</fullTextUrl>
              <keywords><keyword>albendazole monohydrochloride</keyword><keyword>cystic echinococcosis</keyword><keyword>hydatid cyst</keyword><keyword>perforation of cyst</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2019-01-04</publicationDate>
              <volume>3</volume>
              <issue>3</issue>
              <startPage>138</startPage>
              <endPage>141</endPage>
              <doi>10.26663/cts.2019.00026</doi>
              <publisherRecordId>61</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">An extraordinary bullet embolism after gunshot injury: a case report</title>
                <authors>
                              <author>
                                <name>Cenk  Balta</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Thoracic Surgery Clinic, Şanlıurfa Training and Research Hospital, Şanlıurfa, Turkey</affiliationName></affiliationsList><abstract language="eng">Gunshot injuries are the second most common cause of death following motor vehicle accidents.
Embolization due to gunshot bullet is rarely reported in the literature. A 20-year-old male patient
admitted to hospital due to chest pain where radiologic examinations demonstrated a bullet in his thorax.
We learned that he was shot from his leg in Syrian civil war one year ago. This very interesting case of
bullet embolism with its migration to left ventricle was reported.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=61</fullTextUrl>
              <keywords><keyword>gunshot</keyword><keyword>bullet embolism</keyword><keyword>trauma</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2019-01-04</publicationDate>
              <volume>3</volume>
              <issue>3</issue>
              <startPage>142</startPage>
              <endPage>144</endPage>
              <doi>10.26663/cts.2019.00027</doi>
              <publisherRecordId>62</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Intradiaphragmatic bronchogenic cyst: a very rare diaphragmatic mass</title>
                <authors>
                              <author>
                                <name>Goktan  Temiz</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ozgur Omer Yildiz</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Omer Cenap Gulyuz</name>
                                <affiliationId>3</affiliationId>
                              </author>
                              <author>
                                <name>Nurettin  Karaoglanoglu</name>
                                <affiliationId>4</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Adana City Education and Research Hospital, Adana, Turkey</affiliationName><affiliationName affiliationId="2">Department of Thoracic Surgery, Yildirim Beyazit University, Yenimahalle Education and Research Hospital, Ankara, Turkey</affiliationName><affiliationName affiliationId="3">Department of Thoracic Surgery, Adiyaman University Education and Research Hospital, Adiyaman, Turkey</affiliationName><affiliationName affiliationId="4">Department of Thoracic Surgery, Yildirim Beyazit University, Faculty of Medicine, Ankara, Turkey</affiliationName></affiliationsList><abstract language="eng">Bronchogenic cysts are generally asymptomatic and are detected incidentally by radiographic imaging
as a smooth homogeneous mediastinal/pulmonary lesion. Isolated intradiaphragmatic bronchogenic
cysts are extremely rare. Here, we report a case of intradiaphragmatic bronchogenic cyst mimicking
a left lower lobe mass in a 56-year-old man suffering from chest pain. Imaging studies of the chest,
including plain chest radiography and computerized tomography revealed a left sided mass in the lower
zone. The patient underwent surgical resection of the mass. Intradiaphragmatic bronchogenic cyst was
diagnosed by pathology.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=62</fullTextUrl>
              <keywords><keyword>bronchogenic cyst</keyword><keyword>diaphragma</keyword><keyword>mass</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2019-01-04</publicationDate>
              <volume>3</volume>
              <issue>3</issue>
              <startPage>145</startPage>
              <endPage>147</endPage>
              <doi>10.26663/cts.2019.00028</doi>
              <publisherRecordId>63</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Thoracic splenosis: a very rare cause of chest pain</title>
                <authors>
                              <author>
                                <name>Celal Bugra Sezen</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Salih  Bilen</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Cem Emrah Kalafat</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Cemal  Aker</name>
                                <affiliationId>3</affiliationId>
                              </author>
                              <author>
                                <name>Celalettin Ibrahim Kocaturk</name>
                                <affiliationId>4</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Yedikule Chest Disease and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey</affiliationName><affiliationName affiliationId="2">Department of Thoracic Surgery, Mardin State Hospital, Mardin, Turkey</affiliationName><affiliationName affiliationId="3">Department of Thoracic Surgery Burdur State Hospital, Burdur, Turkey</affiliationName><affiliationName affiliationId="4">Department of Thoracic Surgery, İstinye University, Liv Hospital, Istanbul, Turkey</affiliationName></affiliationsList><abstract language="eng">Intrathoracic splenosis presents a rare thoracic lesion occurring after splenectomy or abdominal trauma as
a consequence of heterotopic autotransplantation and implantation of splenic tissue. We present a 38- yearold
man with intrathoracic splenosis. He was admitted to hospital with chest pain. In computed tomography
homogenous, smooth-edged multiple lesions were found. The patient was not able to be diagnosed with
transthoracic fine needle aspiration biopsy. On the exploration, there were multiple lesions at the thoracic
cavity and the masses were excised. Definitive pathology was reported as splenosis.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=63</fullTextUrl>
              <keywords><keyword>thoracic splenosis</keyword><keyword>medical history</keyword><keyword>abdominal trauma</keyword><keyword>chest pain</keyword><keyword>splenectomy</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2019-01-04</publicationDate>
              <volume>3</volume>
              <issue>3</issue>
              <startPage>148</startPage>
              <endPage>151</endPage>
              <doi>10.26663/cts.2019.00029</doi>
              <publisherRecordId>64</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Bilateral pulmonary nodular amyloidosis with positive fdg uptake</title>
                <authors>
                              <author>
                                <name>Koray  Dural</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Berkant  Özpolat</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Nesimi  Günal</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ekin  Zorlu</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Salih  Kür</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Pınar  Atasoy</name>
                                <affiliationId>2</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Kırıkkale University Faculty of Medicine, Kırıkkale, Turkey</affiliationName><affiliationName affiliationId="2">Department of Pathology, Kırıkkale University Faculty of Medicine, Kırıkkale, Turkey</affiliationName></affiliationsList><abstract language="eng">Amyloidosis is a disease characterized by extracellular accumulation of protein in fibrillary structure
(amyloid protein) in various organs and soft tissues. Although the involvement of respiratory system
is encountered in systemic amyloidosis, localized pulmonary amyloidosis has rarely been reported.
The radiologic findings are nonspecific and show variations according to involvement pattern of
amyloidosis. Here we present a 62-year-old female diagnosed as pulmonary nodular amyloidosis with
the help of relevant literature.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=64</fullTextUrl>
              <keywords><keyword>multiple pulmonary nodule</keyword><keyword>metastatic disease</keyword><keyword>pulmonary lesion</keyword><keyword>amyloidosis</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2019-01-04</publicationDate>
              <volume>3</volume>
              <issue>3</issue>
              <startPage>152</startPage>
              <endPage>0</endPage>
              <doi>10.26663/cts.2019.00030</doi>
              <publisherRecordId>65</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Intraoperative findings of spontaneous hemopneumothorax</title>
                <authors>
                              <author>
                                <name>Kuthan  Kavakli</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Hakan  Isik</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Gokhan  Ayberik</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Alper  Gozubuyuk</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, University of Health Sciences, Gülhane Training and Research Hospital, Ankara, Turkey</affiliationName></affiliationsList><abstract language="eng"></abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=65</fullTextUrl>
              <keywords><keyword>hemopneumothorax</keyword><keyword>spontaneous</keyword><keyword>thoracoscopic surgery</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2019-01-04</publicationDate>
              <volume>3</volume>
              <issue>3</issue>
              <startPage>153</startPage>
              <endPage>158</endPage>
              <doi>10.26663/cts.2019.00031</doi>
              <publisherRecordId>66</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Surgical approach for malignant pleural effusion</title>
                <authors>
                              <author>
                                <name>Hasan  Akin</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ali  Kilicgun</name>
                                <affiliationId>2</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Yedikule Chest Disease and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey</affiliationName><affiliationName affiliationId="2">Department of Thoracic Surgery, Bolu Abant Izzet Baysal University, Bolu, Turkey</affiliationName></affiliationsList><abstract language="eng">In this review, the causes of pleural effusion were discussed. Pleural reactions and tumors were explained
in the tables. Subsequently, radiographic findings and their role of guidance in the interventional
procedures were briefly mentioned. Surgical diagnosis and treatment methods were explained.
Malignant mesothelioma was discussed under a separate title. In the end, pleurodesis, a commonly used
method in patients with malignant pleural effusion, was discussed.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=66</fullTextUrl>
              <keywords><keyword>malignant pleural effusion</keyword><keyword>surgery</keyword><keyword>pleural fluid</keyword>
                  </keywords>
            </record></records>